J0736 HCPCS code: Injection, clindamycin phosphate, 300 mg
J0736 is the HCPCS Level II code for injection, clindamycin phosphate, 300 mg. In 2024 Medicare paid an average of $1.68 per service for J0736 across 3,624 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 9 per day on outpatient hospital claims. Medicare volume rose 671% from 2023 to 2024 (470 to 3,624 services). In 2024, about 703 clinicians billed Medicare for J0736 for 1,698 beneficiaries; Texas, California, Mississippi accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J0736 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 703 |
| Medicare beneficiaries | 1,698 |
| States with claims | 26 |
| Share of services in top 3 states (Texas, California, Mississippi) | 34% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0736, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 470 | 242 | $1.79 | $1.40 |
| 2024 | 3,624 | 1,698 | $2.20 | $1.68 |
States with the most J0736 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 439 | $1.62 |
| California | 399 | $1.70 |
| Mississippi | 314 | $1.67 |
| Florida | 258 | $1.83 |
| Alabama | 255 | $1.58 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 9 | Prescribing Information |
| practitioner claims | 9 | Prescribing Information |
What changed for J0736
- 2023-07-01: J0736 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0736?
J0736 is the HCPCS Level II code for injection, clindamycin phosphate, 300 mg. Short descriptor: "Inj, clindamycin phosp 300mg".
How much does Medicare pay for J0736?
In 2024, the average Medicare payment was $1.68 per service (average allowed $2.20).
Does Medicare cover J0736?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0736 can be billed per day?
9 on outpatient hospital claims; 9 on practitioner claims (NCCI medically unlikely edits).
Related J07 codes
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
- J0706 — Injection, caffeine citrate, 5 mg
- J0710 — Injection, cephapirin sodium, up to 1 gm
- J0712 — Injection, ceftaroline fosamil, 10 mg
- J0713 — Injection, ceftazidime, per 500 mg
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g
- J0715 — Injection, ceftizoxime sodium, per 500 mg
- J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0720 — Injection, chloramphenicol sodium succinate, up to 1 gm
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0736
- Watch J0736 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0736
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.